Gingerols

Gingerols at a Glance

Gingerols — chiefly ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol — are the dominant pungent phenolics of fresh ginger, and the molecules responsible for its heat and much of its pharmacology.

They act on TRPV1, the capsaicin receptor, which is why ginger tastes hot, and on 5-HT3 receptors, which is the mechanism behind its well-supported antiemetic use.

They are also transient. Gingerols are near-completely glucuronidated on absorption, and drying ginger converts them to shogaols — so fresh, dried and extracted ginger are chemically different products.

What It's Used For

Gingerols are the main pungent principles of fresh ginger, and “gingerol” chiefly means ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol, the most abundant homolog (with minor 8- and 10-gingerol). Two facts frame the evidence. First, gingerol is thermally labile — on drying or heating it dehydrates to the sharper shogaols and, with further cooking, to milder zingerone — so fresh and dried rhizome differ in their gingerol:shogaol ratio, and any “ginger” result depends on the preparation. Second, and decisively, almost all human efficacy evidence is for whole or standardized ginger extract, not isolated ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol — the isolate’s role is mechanistic. Those mechanisms are well defined: ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol is a 5-HT3 receptor negative allosteric modulator and NK-1 antagonist (the antiemetic basis) ^{1,2Reference 1Marx W et al. · 2017ReviewGinger — mechanism of action in chemotherapy-induced nausea and vomiting: a reviewView study →Reference 2Al Kury LT et al. · 2018Natural negative allosteric modulators of 5-HT3 receptorsView study →} and a TRPV1 agonist ^{8Reference 8Yin Y et al. · 2019Structural mechanisms underlying activation of TRPV1 channels by pungent compounds in gingersView study →}, and it inhibits COX/LOX and NF-κB inflammatory signaling ^{3,10Reference 3Jalali M et al. · 2020Meta-analysisThe effects of ginger supplementation on markers of inflammatory and oxidative stress: a systematic review and meta-analysisView study →Reference 10Jeong CH et al. · 2009Jeong CH, et al. (2009). [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Research. https://pubmed.ncbi.nlm.nih.gov/19531649/View study →}.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. The human evidence is for ginger, not the isolate, so isolate scores stay low by design. Each application links to its write-up.

01Anti-nausea (antiemetic)Promising50%Ginger-extract RCT meta-analyses + isolate 5-HT3/NK-1 mechanism ^{1,2,13Reference 1Marx W et al. · 2017ReviewGinger — mechanism of action in chemotherapy-induced nausea and vomiting: a reviewView study →Reference 2Al Kury LT et al. · 2018Natural negative allosteric modulators of 5-HT3 receptorsView study →Reference 13Viljoen E et al. · 2014Meta-analysisA systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomitingView study →}

02Anti-inflammatory / OA / dysmenorrheaShaky44%Ginger-extract meta-analyses + isolate COX/NF-κB ^{3,4Reference 3Jalali M et al. · 2020Meta-analysisThe effects of ginger supplementation on markers of inflammatory and oxidative stress: a systematic review and meta-analysisView study →Reference 4Sheikhhossein F et al. · 2021Meta-analysisEffects of ginger supplementation on biomarkers of oxidative stress: a systematic review and meta-analysis of RCTsView study →}

03Metabolic / glycemicShaky32%Ginger meta-analyses, mixed/conflicting ^{11,12Reference 11Ebrahimzadeh A et al. · 2022Meta-analysisThe effect of ginger supplementation on metabolic profiles in patients with type-2 diabetes mellitus: a systematic review and meta-analysis of RCTsView study →Reference 12Huang FY et al. · 2019Meta-analysisDietary ginger as a traditional therapy for blood-sugar control in patients with type-2 diabetes mellitus: a systematic review and meta-analysisView study →}

04GI motility / prokineticShaky26%Preclinical TRPV1 mechanism ^{8,9Reference 8Yin Y et al. · 2019Structural mechanisms underlying activation of TRPV1 channels by pungent compounds in gingersView study →Reference 9Okumi H et al. · 2012AnimalDietary agonists of TRPV1 inhibit gastric acid secretion in miceView study →}

05AnticancerShaky20%Cell/animal only ^{10Reference 10Jeong CH et al. · 2009Jeong CH, et al. (2009). [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Research. https://pubmed.ncbi.nlm.nih.gov/19531649/View study →}

Mechanisms

Pharmacokinetics

Load-bearing and human-verified. In healthy volunteers given single oral ginger doses of 100–2000 mg, no participant had detectable free ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-, ^{8Reference 8Yin Y et al. · 2019Structural mechanisms underlying activation of TRPV1 channels by pungent compounds in gingersView study →}-, ^{10Reference 10Jeong CH et al. · 2009Jeong CH, et al. (2009). [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Research. https://pubmed.ncbi.nlm.nih.gov/19531649/View study →}-gingerol or ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-shogaol in plasma — all circulated essentially entirely as glucuronide (and sulfate) conjugates, indicating rapid, near-complete presystemic conjugation ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}. Conjugated ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol appeared within about an hour and cleared over roughly 1–3-hour half-lives ^{6,7Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →Reference 7Yu Y et al. · 2011Examination of the pharmacokinetics of active ingredients of ginger in humansView study →}. Net: rapid absorption, extensive first-pass glucuronidation and very low free-drug plasma exposure — the same “conjugated-not-free” pattern seen with curcumin, and a key limit on isolate systemic activity. The thermal conversion of gingerol to shogaol on drying/heating also means fresh (Sheng Jiang) and dried (Gan Jiang) ginger deliver different actives.

Clinical trials

There are essentially no isolated ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol human efficacy trials. All positive human evidence is whole/standardized ginger: pregnancy nausea ^{13Reference 13Viljoen E et al. · 2014Meta-analysisA systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomitingView study →}, inflammation/oxidative markers ^{3,4Reference 3Jalali M et al. · 2020Meta-analysisThe effects of ginger supplementation on markers of inflammatory and oxidative stress: a systematic review and meta-analysisView study →Reference 4Sheikhhossein F et al. · 2021Meta-analysisEffects of ginger supplementation on biomarkers of oxidative stress: a systematic review and meta-analysis of RCTsView study →} and glycemic endpoints ^{11,12Reference 11Ebrahimzadeh A et al. · 2022Meta-analysisThe effect of ginger supplementation on metabolic profiles in patients with type-2 diabetes mellitus: a systematic review and meta-analysis of RCTsView study →Reference 12Huang FY et al. · 2019Meta-analysisDietary ginger as a traditional therapy for blood-sugar control in patients with type-2 diabetes mellitus: a systematic review and meta-analysisView study →}; the human pharmacokinetic studies dosed ginger extract and measured gingerol/shogaol conjugates ^{6,7Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →Reference 7Yu Y et al. · 2011Examination of the pharmacokinetics of active ingredients of ginger in humansView study →}. Attribute efficacy to “ginger,” not the isolate.

Last checked: July 2026.

Toxicity & Safety

Ginger and its gingerols are recognized as safe at culinary levels and were well tolerated in human pharmacokinetic dosing up to a 2 g single dose ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}. The main practical caution is antiplatelet activity: gingerols inhibit thromboxane synthesis and platelet aggregation ^{5Reference 5Hirsch GE et al. · 2017Natural products with antiplatelet actionView study →}, so caution is reasonable with anticoagulants or antiplatelets (warfarin, DOACs, aspirin, clopidogrel) and around surgery — though clinical bleeding events are rare and mostly theoretical. High intakes can cause heartburn, reflux or mild GI upset. Additive glucose- and blood-pressure-lowering are plausible, and a CYP interaction is in-vitro only — do not assert it as a confirmed human interaction.

Dosage

There is no established isolated-^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol human dose. Efficacy trials clustered around 0.5–2 g/day of standardized dried ginger, and human pharmacokinetic dose-ranging used single ginger doses of 100–2000 mg ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →} — all ginger extract, not the isolate. Nothing here is a recommendation.

References

1. Marx W, et al. (2017). Ginger — mechanism of action in chemotherapy-induced nausea and vomiting: a review. Critical Reviews in Food Science and Nutrition. https://pubmed.ncbi.nlm.nih.gov/25848702/
2. Al Kury LT, et al. (2018). Natural negative allosteric modulators of 5-HT3 receptors. Molecules. https://pubmed.ncbi.nlm.nih.gov/30513973/
3. Jalali M, et al. (2020). The effects of ginger supplementation on markers of inflammatory and oxidative stress: a systematic review and meta-analysis. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/32147845/
4. Sheikhhossein F, et al. (2021). Effects of ginger supplementation on biomarkers of oxidative stress: a systematic review and meta-analysis of RCTs. Clinical Nutrition ESPEN. https://pubmed.ncbi.nlm.nih.gov/34620306/
5. Hirsch GE, et al. (2017). Natural products with antiplatelet action. Current Pharmaceutical Design. https://pubmed.ncbi.nlm.nih.gov/27881059/
6. Zick SM, et al. (2008). Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiology, Biomarkers & Prevention. https://pubmed.ncbi.nlm.nih.gov/18708382/
7. Yu Y, et al. (2011). Examination of the pharmacokinetics of active ingredients of ginger in humans. The AAPS Journal. https://pubmed.ncbi.nlm.nih.gov/21638149/
8. Yin Y, et al. (2019). Structural mechanisms underlying activation of TRPV1 channels by pungent compounds in gingers. British Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/31207668/
9. Okumi H, Tashima K, Matsumoto K, et al. (2012). Dietary agonists of TRPV1 inhibit gastric acid secretion in mice. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/23047250/
10. Jeong CH, et al. (2009). [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Research. https://pubmed.ncbi.nlm.nih.gov/19531649/
11. Ebrahimzadeh A, Ebrahimzadeh A, Mirghazanfari SM, et al. (2022). The effect of ginger supplementation on metabolic profiles in patients with type-2 diabetes mellitus: a systematic review and meta-analysis of RCTs. Complementary Therapies in Medicine. https://pubmed.ncbi.nlm.nih.gov/35031435/
12. Huang FY, Deng T, Meng LX, et al. (2019). Dietary ginger as a traditional therapy for blood-sugar control in patients with type-2 diabetes mellitus: a systematic review and meta-analysis. Medicine (Baltimore). https://pubmed.ncbi.nlm.nih.gov/30921234/
13. Viljoen E, et al. (2014). A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutrition Journal. https://pubmed.ncbi.nlm.nih.gov/24642205/

View all 13 references▾